Vimarsana
Biggest News Aggregation in the World

Page 2 - Maureen Testoni News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maureen Testoni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maureen Testoni Today - Breaking & Trending Today

Guidance change threatens hospital 340B drug discounts - Vimarsana News

Guidance change threatens hospital 340B drug discounts

Healthcare

Teva to stop sending 340B-discounted drugs to contract pharmacies - Vimarsana News

Teva to stop sending 340B-discounted drugs to contract pharmacies

Teva Pharmaceuticals will stop shipping 36 discounted drugs to contract pharmacies in July, citing concerns of a diluted 340B program.

340B drug discount program faces uncertainties amid HRSA silence - Vimarsana News

340B drug discount program faces uncertainties amid HRSA silence

A change in guidance could translate to the loss of tens of millions of dollars in expected annual savings for some hospitals with broad outpatient networks.

340B reporting mandate approved by House subcommittee, legislation moves forward - Vimarsana News

340B reporting mandate approved by House subcommittee, legislation moves forward

Legislation to increase transparency and oversight of the 340B drug discount program was passed by the House Energy and Commerce Committee's Subcommittee on Health.

Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices – South Dakota War College - Vimarsana News

Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices – South Dakota War College

Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices Washington, D.C. – Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit health insurers and PBMs from discriminating against 340B Drug Pricing Program providers or their contract pharmacies on the basis of their status…